Agilent to fund biotherapy incubator in India
Agilent Technologies has announced a partnership with the Indian Institute of Technology Delhi to advance biotherapeutic research in the country. Read More
Joint venture targets cell and gene therapy
A new joint venture dedicated to supporting researchers and biopharmaceutical companies in cell and gene therapy was announced on January 21. The joint venture is owned equally by three partners: Bio-Techne, Fresenius Kabi, and Wilson Wolf. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter